AstraZeneca Pharma India Ltd

NSE: ASTRAZEN · BSE: 506820 · Pharmaceuticals & Biotechnology · 42 announcements

Share price: ₹5,927.00
Market cap: ₹14,818 Cr
Revenue (annual): ₹2,276 Cr
Net profit (annual): ₹187.5 Cr
P/E (TTM): 87.4×Sector 47.4×
Promoter holding: 75.00%+0.00% QoQ
FII holding: 2.68%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 8 Regulatory Approval 6 Legal & Regulatory 6 Other Announcement 5 Annual General Meeting 4 Financial Results 3 Results Update 2 Dividend 2 Board Meeting Date 2 Capacity Expansion 1 Business Update 1 Annual Report 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

12 May 2026 13:55 IST BSE

Capacity Expansion

AstraZeneca Pharma India Capacity Expansion

AstraZeneca Pharma India's shareholders approved shifting its Registered Office from Karnataka to Maharashtra. This relocation follows a special resolution and remains subject to regulatory approvals.

Read the filing ↗